Skip to main content

Management of Risks Factors for Older Women: Osteoporosis and Cardiovascular Disease

  • Reference work entry
  • First Online:
  • 1930 Accesses

Abstract

Osteoporosis and cardiovascular disease are common conditions in older women, with a high prevalence and associated morbidity and mortality after the menopausal transition. Osteoporosis is more common in women than in men, occurring primarily after menopause when estrogen levels drop. Fractures are the most concerning complication of osteoporosis in women, with the hip, vertebrae, and forearm as the most common sites of fracture. Risk factors and non-pharmacologic prevention, diagnosis, and pharmacologic management are reviewed in this chapter. New attitudes toward the use of hormone replacement are also addressed.

Cardiovascular (CV) disease is the leading cause of death for women in the United States. Risk factors for cardiovascular disease are discussed in this chapter, specifically those unique to women such as polycystic ovarian syndrome, menopause, and certain complications of pregnancy.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • ACOG Osteoporosis Guidelines Issued. August 21, 2012 acog.org/About-ACOG/News-Releases/2012/Osteoporosis Guidelines-Issued last assessed Nov 13, 2016.

    Google Scholar 

  • ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. osteoporosis, Number 129, September 2012, reaffirmed 2014.

    Google Scholar 

  • Acog.org/Resources%20And%20Publications/Practice%20Bulletins/Committee%20on%20oPractice%20Bulletins%20Gynecology/Osteoporosis.aspx last assessed November 12, 2016.

    Google Scholar 

  • Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women’s health Initiative randomized controlled trial. JAMA. 2004;291:1701–12.

    Article  CAS  PubMed  Google Scholar 

  • Bellamy L, Casas JP, Hingorani AD, Williams D. Type2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–9.

    Article  CAS  PubMed  Google Scholar 

  • Bouillon R, et al. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med. 1991;90:107–10.

    Article  Google Scholar 

  • Cosman F, Lindsay R, LeBoff MS, Jan de Beur S, Tanner B, Dawson-Hughes B, Khosla S, Melton LJ, Tosteson ANA, Favus M, Baim S. Clinician’s guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2013.

    Google Scholar 

  • Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279(20):1615–22.

    Article  CAS  Google Scholar 

  • Goff Jr DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino Sr RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith Jr SC, Sorlie P, Kessous R, Shoham-Vardi I, Pariente G, et al. An association between preterm delivery and long-term maternal cardiovascular morbidity. Am J Obstet Gynecol. 2013;209(4):368. e1–8.

    Google Scholar 

  • Hodis HN, Mack WJ, Henderson VW, Shoupe D, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016;374:1221–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • International Osteoporosis Foundation. Women over 50 will experience osteoporotic fractures, as wil men. Facts and statistics. Iofbonehealth.org/‘facts-statistics last asssessed November 13, 2016.

    Google Scholar 

  • James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) [published erratum appears in JAMA 2014;311(17):1809]. JAMA. 2014;311(5):507–20.

    Article  CAS  PubMed  Google Scholar 

  • Keaney JF, Solomon CG. Postmenopausal hormone therapy and atherosclerosis- time is of the essence. N Engl J Med. 2016;374:1279–80.

    Article  CAS  PubMed  Google Scholar 

  • Kharazmi E, Dossus L, Rohrmann S, et al. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart. 2011;97(1):49.

    Article  PubMed  Google Scholar 

  • Lyles KW, Colón-Emeric CS, Magaziner JS. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357:1799.

    Article  CAS  PubMed  Google Scholar 

  • Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med. 2007;356:2591–602.

    Article  CAS  PubMed  Google Scholar 

  • Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308:1583–7.

    Article  CAS  PubMed  Google Scholar 

  • Mosekilde L, Beck-Nielsen H, Sorensen OH, Nielsen SP, Charles P, Vestergaard P, et al. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women – results of the Danish Osteoporosis Prevention Study. Maturitas. 2000;36:181–93.

    Article  CAS  PubMed  Google Scholar 

  • Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial. Lancet. 2006;368(9542):1155–63.

    Article  CAS  PubMed  Google Scholar 

  • National Osteoporosis Foundation (NOF). 2015 [cited 18 April 2015]. Available from: www.nof.org.

  • NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. 1994 [cited 18 April 2015]; JAMA 272(24):1942.

    Google Scholar 

  • Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental – syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797–803.

    Article  PubMed  Google Scholar 

  • Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–207.

    Article  CAS  PubMed  Google Scholar 

  • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Writing group for the women’s health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.

    Article  CAS  PubMed  Google Scholar 

  • Salley KE, Wickham EP, Cheang KI, et al. Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab. 2007;92:4546.

    Article  CAS  PubMed  Google Scholar 

  • Sampson HW. Alcohol and other factors affecting osteoporosis risk in women. NIH National Institute of Alcohol Abuse and Alcoholism [Internet]. 2003 [cited 18 April 2015]. Available from: http://pubs.niaaa.nih.gov/publications/arh26-4/292-298.htm.

  • Schierbeck LL, Rejnmark L, Tofteng CL L, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomized trial. BMJ. 2012;345:e6409.

    Article  PubMed  Google Scholar 

  • Srivastava M, Deal C. Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med. 2002;18:529–55.

    Article  PubMed  Google Scholar 

  • Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014a;129(25 Suppl 2):S5.

    Article  Google Scholar 

  • Stone NJ, Wilson PW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014b;63(25 Pt B):2935–59.

    PubMed  Google Scholar 

  • WHO Technical Report Series. Prevention and management of osteoporosis. Geneva: World Health Organization; 2003.

    Google Scholar 

  • Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. Jama. 2002;288.3:321–33.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katrina Wade .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Wade, K., Quaas, A.M. (2017). Management of Risks Factors for Older Women: Osteoporosis and Cardiovascular Disease. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-17798-4_47

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17798-4_47

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17797-7

  • Online ISBN: 978-3-319-17798-4

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics